APA (7th ed.) Citation

Soler‐Cedeño, O., Keegan, B. M., Alton, H., Bi, G., Linz, E., Vogt, C. D., . . . Xi, Z. (2025). ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents. British Journal of Pharmacology, 182(13), 2997. https://doi.org/10.1111/bph.70021

Chicago Style (17th ed.) Citation

Soler‐Cedeño, Omar, et al. "ESG‐1‐60 and ESG‐1‐61: Novel Dopamine D3 Receptor‐preferring Partial Agonists/antagonists That Inhibit Cocaine Taking and Seeking in Rodents." British Journal of Pharmacology 182, no. 13 (2025): 2997. https://doi.org/10.1111/bph.70021.

MLA (9th ed.) Citation

Soler‐Cedeño, Omar, et al. "ESG‐1‐60 and ESG‐1‐61: Novel Dopamine D3 Receptor‐preferring Partial Agonists/antagonists That Inhibit Cocaine Taking and Seeking in Rodents." British Journal of Pharmacology, vol. 182, no. 13, 2025, p. 2997, https://doi.org/10.1111/bph.70021.